Physician profile
Eric Christopher Flavill
NPI 1417157249
$2,287.49
in general payments reported to CMS, 2019-2025
31 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $122 · 2021: $215 · 2022: $641 · 2023: $267 · 2024: $357 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $980.84 | 2019-2023 | 1788 |
| Genzyme Corporation | $231.42 | 2022-2025 | |
| Smith+Nephew, INC. | $120.23 | 2024 | Halo, Coblation, Tula |
| Steris Corporation | $117.91 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $92.81 | 2022 | |
| Nevro Corp. | $85.25 | 2022 | |
| Novo Nordisk INC | $63.64 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $48.88 | 2021-2022 | |
| Optinose US, INC. | $44.68 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $40.31 | 2021 | |
| Lundbeck LLC | $40.11 | 2023-2024 | Vyepti, Rexulti |
| Intersect Ent, INC. | $38.98 | 2020 | |
| Karl Storz Endoscopy-America | $33.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.90 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.36 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $27.49 | 2023 | |
| Acclarent, INC | $26.85 | 2023 | Trudi Nav Cable |
| Pfizer INC. | $24.79 | 2024 | |
| Aerin Medical INC. | $23.92 | 2022 | |
| Ambu INC. | $21.16 | 2023 | |
| Acera Surgical, INC. | $18.37 | 2020 | |
| Medtronic, INC. | $17.13 | 2023 | Inpen Smart Insulin Delivery System |
| Scilex Pharmaceuticals INC. | $16.09 | 2024 | |
| Dexcom, INC. | $16.02 | 2024 | Dexcom G6 Transmitter |
| Misonix INC | $15.46 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.82 | 2022 | |
| Inspire Medical Systems, INC. | $14.37 | 2023 | Inspire |
| Hikma Pharmaceuticals USA | $14.31 | 2023 | Ryaltris |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.83 | 2022 | |
| Ethicon US, LLC | $13.63 | 2022 | |
| Acerus Pharmaceuticals Corporation | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Flavill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.